These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11826560)

  • 1. Frovatriptan approved as migraine treatment.
    Thompson CA
    Am J Health Syst Pharm; 2002 Jan; 59(2):116, 120. PubMed ID: 11826560
    [No Abstract]   [Full Text] [Related]  

  • 2. When to use frovatriptan in migraine?
    Tfelt-Hansen PC
    J Headache Pain; 2011 Jun; 12(3):393-4; author reply 395-6. PubMed ID: 21512776
    [No Abstract]   [Full Text] [Related]  

  • 3. The truth about frovatriptan.
    Tfelt-Hansen P; Steiner T
    Headache; 2003 Jun; 43(6):699-700; author reply 697-9. PubMed ID: 12786937
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological profile and clinical characteristics of frovatriptan in the acute treatment of migraine: introduction.
    Silberstein SD
    Headache; 2002 Apr; 42 Suppl 2():S45-6. PubMed ID: 12028319
    [No Abstract]   [Full Text] [Related]  

  • 5. Frovatriptan review.
    Markus F; Mikko K
    Expert Opin Pharmacother; 2007 Dec; 8(17):3029-33. PubMed ID: 18001261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frovatriptan.
    Easthope SE; Goa KL
    CNS Drugs; 2001; 15(12):969-76; discussion 977-8. PubMed ID: 11735616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine.
    Balbisi EA
    Int J Clin Pract; 2004 Jul; 58(7):695-705. PubMed ID: 15311727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and tolerability of frovatriptan and dexketoprofen for the treatment of acute migraine attacks.
    Allais G; Rolando S; De Lorenzo C; Benedetto C
    Expert Rev Neurother; 2014 Aug; 14(8):867-77. PubMed ID: 25056381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with frovatriptan response in patients with migraine: A prospective, observational study.
    Seo JG; Park SP
    Cephalalgia; 2016 Apr; 36(5):493-8. PubMed ID: 26170008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of frovatriptan: placebo-controlled studies.
    Ryan R; Géraud G; Goldstein J; Cady R; Keywood C
    Headache; 2002 Apr; 42 Suppl 2():S84-92. PubMed ID: 12028324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study.
    Newman LC; Harper S; Jones BA; Campbell J
    J Womens Health (Larchmt); 2009 Aug; 18(8):1265-73. PubMed ID: 19627225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Silberstein SD; Elkind AH; Schreiber C; Keywood C
    Neurology; 2004 Jul; 63(2):261-9. PubMed ID: 15277618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic evaluation of frovatriptan.
    Negro A; Lionetto L; Casolla B; Lala N; Simmaco M; Martelletti P
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1449-58. PubMed ID: 21929465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment response and tolerability of frovatriptan in patients reporting short- or long-duration migraines at baseline.
    Kelman L; Harper SQ; Hu X; Campbell JC
    Curr Med Res Opin; 2010 Sep; 26(9):2097-104. PubMed ID: 20642390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Meta-analysis of triptan treatment in migraine].
    Nakashima K; Takeshima T; Kowa H
    No To Shinkei; 2004 Sep; 56(9):747-52. PubMed ID: 15552863
    [No Abstract]   [Full Text] [Related]  

  • 16. [Frovatriptan possibly causing acute myocardial infarction].
    Møller-Helgestad OK; Kaltoft AK; Kasch H
    Ugeskr Laeger; 2015 Mar; 177(13):V10140537. PubMed ID: 25822816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frovatriptan: pharmacological differences and clinical results.
    Rapoport AM
    Curr Med Res Opin; 2001; 17 Suppl 1():s68-70. PubMed ID: 12463282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studies.
    Saracco MG; Allais G; Tullo V; Zava D; Pezzola D; Reggiardo G; Omboni S; Benedetto C; Bussone G; Aguggia M
    Neurol Sci; 2014 May; 35 Suppl 1():115-9. PubMed ID: 24867847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study.
    Göbel H; Heinze A
    Int J Clin Pract; 2011 Aug; 65(8):879-86. PubMed ID: 21762313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral naratriptan approved for migraine attacks.
    Am J Health Syst Pharm; 1998 Apr; 55(7):638. PubMed ID: 9558416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.